The recent pandemic situation has begun the rat race between vaccine developers to
launch vaccine for COVID-19. This vaccine has gained momentum with industry-institute collaborations to address the global need. This panel will discuss the strategies adopted by regulatory bodies, biopharma companies and institutes to develop most studied vaccines. Where do we stand and navigate through clinical trial complexities to ensure safety and efficacy.